How to Help Your Patients Save Money on Montelukast: A Provider's Guide to Savings Programs

Medication affordability is one of the most common barriers to adherence in patients with chronic asthma and allergic rhinitis. While generic montelukast is among the more affordable medications available — particularly with discount programs — some patients still face significant out-of-pocket costs. This guide gives providers a practical toolkit for helping patients access montelukast affordably.

Understanding Montelukast Pricing in 2026

Generic montelukast is generally accessible, but pricing can still be a barrier for uninsured or underinsured patients:

Retail cash price (10 mg, 30-day supply): $15–$145, depending on pharmacy and location

With GoodRx/SingleCare coupon (10 mg, 30-day supply): As low as $4–$13

With insurance (most plans): $0–$30 copay (Tier 1 on most formularies)

Brand-name Singulair: ~$289/month retail; often non-formulary; no manufacturer copay card available for a branded product that faces generic competition

Formulary Tier and Insurance Coverage

Generic montelukast is covered by nearly all commercial insurance plans, Medicare Part D, and Medicaid without prior authorization. It is typically placed on Tier 1 (preferred generic) — the lowest copay tier — because so many manufacturers produce it. This is important context for patient counseling: most insured patients should be paying very little for generic montelukast.

If a patient reports high out-of-pocket costs despite insurance, investigate:

Are they being dispensed brand-name Singulair instead of generic? (Some insurers default to the brand unless a generic is specified or substitution is allowed by state law.)

Are they using a high-deductible plan where they haven't yet met their deductible?

Is their plan requiring step therapy (e.g., requiring an antihistamine first) for an allergic rhinitis indication?

Key Savings Strategies to Share With Patients

1. Prescription Discount Cards (GoodRx, SingleCare)

GoodRx and SingleCare are both free, require no enrollment, and are accepted at most major pharmacy chains. These are the fastest and most universally applicable savings tools for uninsured or high-deductible patients.

GoodRx: goodrx.com — provides pharmacy-specific coupons; prices vary by location but can reduce a 30-day supply of generic montelukast to $4–$13

SingleCare: singlecare.com — in some cases beats GoodRx pricing; 90-day supply as low as $9.44 at participating pharmacies

Important note for providers: In some cases, the GoodRx or SingleCare cash price may be lower than the patient's insurance copay — especially for patients on high-deductible plans. Patients cannot use both insurance and a discount card for the same prescription, so encourage them to compare.

2. Prescribe 90-Day Supplies

For patients taking montelukast daily for chronic conditions (persistent asthma, perennial AR), prescribing a 90-day supply reduces cost per dose, reduces pharmacy trips, and builds in a supply buffer. Most commercial plans and Medicare Part D plans offer lower per-dose copays for 90-day mail-order fills. Instruct patients to use their plan's preferred mail-order pharmacy for maximum savings.

3. Patient Assistance Programs

For patients without insurance or with very high cost-sharing, formal patient assistance programs may provide additional support:

HealthWell Foundation Urticaria Fund: 1-800-675-8416 | healthwellfoundation.org/fund/urticaria — for patients with chronic urticaria who have insurance coverage; provides copay assistance

NeedyMeds.org: Comprehensive database of PAPs, disease-specific foundations, and free/reduced-cost clinic programs

pparx.org: Partnership for Prescription Assistance — connects patients to PAPs, state pharmaceutical programs, and manufacturer assistance; searchable by medication

State pharmaceutical assistance programs: Many states offer prescription assistance for low-income residents who don't qualify for Medicaid — particularly for elderly patients

4. Federally Qualified Health Centers (FQHCs)

Uninsured or underinsured patients who are seen at federally qualified health centers (FQHCs) may have access to 340B pricing on montelukast, which is dramatically below market rates. If you work in a 340B-participating institution, this is often the most cost-effective option for your most financially vulnerable patients.

5. Encourage Generic Substitution

When prescribing montelukast, write "generic substitution permitted" or "montelukast sodium" specifically (rather than Singulair) to ensure the pharmacist dispenses the lower-cost generic. Generic montelukast is FDA-confirmed to be therapeutically equivalent to Singulair — there is no clinical reason to specify the brand for the vast majority of patients.

6. Use HSA/FSA Funds

Remind patients with Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs) that montelukast is a qualifying medical expense. Paying with pre-tax HSA/FSA dollars effectively reduces the real cost by the patient's marginal tax rate — often 22–32% for working adults.

How medfinder Supports Patient Access

Cost isn't the only barrier — patients also face difficulty finding montelukast in stock at their local pharmacy. medfinder for providers helps by calling pharmacies near the patient to identify which ones can fill the prescription. You can direct patients to medfinder.com as a supplemental access resource. For patient-facing savings information to share in your waiting room or patient portal, see how to save money on montelukast in 2026.